A survey evaluating the awareness of MRONJ within the Birmingham GAAP community

摘要

Introduction: A number of patients are routinely prescribed antiresorptive drugs that can be associated with developing medication-related osteonecrosis of the jaw (MRONJ). When presenting to a dental setting, the majority are unaware of the small but relative risk of developing MRONJ. Prevention is currently the only evidence-based method of reducing the incidence of MRONJ. Raising awareness of MRONJ could encourage GMPs to liaise with dental clinicians for premedication screening, preventative advice and specialist referrals. Methods: An electronic survey consisting of 16 multiple-choice questions, targeting GMPs and GMP trainees in Birmingham was conducted to evaluate their knowledge and awareness of MRONJ. A section for open comments was available. This was conducted between March and May 2016.